Literature DB >> 17525470

The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160.

Jayita Sen1, Amy Jacobs, Haiqing Jiang, Lijun Rong, Michael Caffrey.   

Abstract

The importance of the HIV gp41 conserved disulfide loop to envelope function has been examined by mutational and functional analyses. Based on a luciferase-reporter entry assay, mutants gp41-CC/AA (C598A/C604A) and gp41-Delta (deletion of residues 596-606) result in a nonfunctional envelope protein. Western blot analysis shows both mutants to be properly expressed but not processed to form gp120 and gp41, which explains their nonfunctionality. The presence of mutant gp160 on the cell surface, as well as their ability to bind to sCD4, suggests that the mutations have disrupted processing at the furin recognition site encoded within the gp120 conserved domain 5, without resulting in an overall misfolding of the protein. With respect to the furin recognition site, the mutations are sequentially distant, which implies that the gp41 disulfide loop is interacting with gp120 C5 in gp160. In addition, we have modeled the gp120-gp41 interaction in unprocessed precursor gp160 using structural data available for gp120 and gp41 domains in isolation, supplemented by mutagenesis data. We suggest that the mutations have altered the interaction between gp120 C5 and the gp41 disulfide loop, resulting in decreased accessibility of the furin recognition site and implying that the interaction between the gp120 C5 and gp41 loop is a conformational requirement for gp160 processing. The sensitivity of this interaction could be exploited in future antivirals designed to disrupt HIV pathogenesis by disrupting gp160 processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525470      PMCID: PMC2206660          DOI: 10.1110/ps.072771407

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop.

Authors:  M Caffrey
Journal:  Biochim Biophys Acta       Date:  2001-05-31

2.  Solution structure of the HIV gp120 C5 domain.

Authors:  Laure Guilhaudis; Amy Jacobs; Michael Caffrey
Journal:  Eur J Biochem       Date:  2002-10

3.  Role of hydrophobic residues in the central ectodomain of gp41 in maintaining the association between human immunodeficiency virus type 1 envelope glycoprotein subunits gp120 and gp41.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage.

Authors:  D Dedera; R L Gu; L Ratner
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.

Authors:  A L Maerz; H E Drummer; K A Wilson; P Poumbourios
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity.

Authors:  W J Syu; W R Lee; B Du; Q C Yu; M Essex; T H Lee
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 10.  The HIV Env-mediated fusion reaction.

Authors:  Stephen A Gallo; Catherine M Finnegan; Mathias Viard; Yossef Raviv; Antony Dimitrov; Satinder S Rawat; Anu Puri; Stewart Durell; Robert Blumenthal
Journal:  Biochim Biophys Acta       Date:  2003-07-11
View more
  16 in total

1.  Short communication: Simultaneous substitutions of V38M and N43T-N44K in the gp41 heptad repeat 1 (HR1) disrupt HIV type 1 gPr160 endoproteolytic cleavage (*).

Authors:  V A Morozov; A V Morozov; S Lagaye
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

2.  Role of the HIV gp120 conserved domain 1 in processing and viral entry.

Authors:  Jizhen Wang; Jayita Sen; Lijun Rong; Michael Caffrey
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

3.  Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.

Authors:  Avraham Ashkenazi; Mathias Viard; Yael Wexler-Cohen; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2011-03-23       Impact factor: 5.191

4.  Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.

Authors:  Fadia Manssour-Triedo; Sara Crespillo; Bertrand Morel; Salvador Casares; Pedro L Mateo; Frank Notka; Marie G Roger; Nicolas Mouz; Raphaelle El-Habib; Francisco Conejero-Lara
Journal:  Biophys J       Date:  2016-08-23       Impact factor: 4.033

5.  A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Authors:  Edward J Murray; Daniel P Leaman; Nishant Pawa; Hannah Perkins; Chris Pickford; Manos Perros; Michael B Zwick; Scott L Butler
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

6.  Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.

Authors:  Lisa Egerer; Andreas Volk; Joerg Kahle; Janine Kimpel; Frances Brauer; Felix G Hermann; Dorothee von Laer
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

Review 7.  Epitope target structures of Fc-mediated effector function during HIV-1 acquisition.

Authors:  George K Lewis; Yongjun Guan; Roberta Kamin-Lewis; Mohammad Sajadi; Marzena Pazgier; Anthony L Devico
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

Review 8.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

9.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

10.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.